Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $17.4 million.

  • Sanara MedTech's Total Current Liabilities rose 2104.73% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.4 million, marking a year-over-year increase of 2104.73%. This contributed to the annual value of $15.3 million for FY2024, which is 1105.61% up from last year.
  • Latest data reveals that Sanara MedTech reported Total Current Liabilities of $17.4 million as of Q3 2025, which was up 2104.73% from $14.9 million recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Total Current Liabilities peaked at $17.4 million during Q3 2025, and registered a low of $3.1 million during Q1 2021.
  • In the last 5 years, Sanara MedTech's Total Current Liabilities had a median value of $11.6 million in 2024 and averaged $10.4 million.
  • As far as peak fluctuations go, Sanara MedTech's Total Current Liabilities surged by 12138.69% in 2022, and later skyrocketed by 419.72% in 2025.
  • Quarter analysis of 5 years shows Sanara MedTech's Total Current Liabilities stood at $6.0 million in 2021, then skyrocketed by 112.65% to $12.8 million in 2022, then grew by 7.51% to $13.8 million in 2023, then increased by 11.06% to $15.3 million in 2024, then increased by 13.52% to $17.4 million in 2025.
  • Its last three reported values are $17.4 million in Q3 2025, $14.9 million for Q2 2025, and $13.3 million during Q1 2025.